Paychex, Inc. PAYX

NASDAQ · Industrials · Staffing & Employment Services

$112.63

Close on Fri, 20 Nov 2026 · market value $40.1B

What the price is betting on

Below its record

At $113, the price assumes revenue grows about 3.9% a year for five years, from $6.6B to about $7.9B by FY2031. That is less than what analysts expect for the next two years and less than the company's own last three years.

The price assumes3.9%
Analysts, next two years5.4%
Last 3 years8.9%

Revenue growth a year. The price figure comes from a reverse DCF at a 8.3% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than PAYX? Check up to 5 of your stocks at once, free, no account.

0$2B$4B$6B$8B$6.6B'23'24'25'26Aug '26'27'28'29'30'31What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$109

Base

$122

Bull

$138

Today $113

  • Bear $109. Cash flow grows 3% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $122. Cash flow grows 5% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $138. Cash flow grows 8% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2027$6.8B$6.9B, on the path
  3. FY2028$7.1B$7.2B, on the path
  4. FY2029$7.3B$7.6B, on the path
  5. FY2030$7.6BNo estimate yet
  6. FY2031$7.9BThe full bet

Each year's revenue at 3.9% growth from $6.6B in the 12 months to August 2026.

At a glance

Industrials · Staffing & Employment Services · listed on NASDAQ

Revenue, FY2026
$6.5B
Growth, 3 years a year
8.9%
Cash margin
36%
Net debt
$3.5B
Shares, 3-year change
−0.6%
Dividend yield
4%

What other industrials prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.